- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7517
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Therapy of chronic hepatitis C in people who inject drugs: focus on adherence ; volume:18 ; number:1 ; day:30 ; month:6 ; year:2021 ; pages:1-9 ; date:12.2021
Harm reduction journal ; 18, Heft 1 (30.6.2021), 1-9, 12.2021
- Creator
-
Frankova, Sona
Jandova, Zuzana
Jinochova, Gabriela
Kreidlova, Miluse
Merta, Dusan
Sperl, Jan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12954-021-00519-y
- URN
-
urn:nbn:de:101:1-2021101221450914311442
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Frankova, Sona
- Jandova, Zuzana
- Jinochova, Gabriela
- Kreidlova, Miluse
- Merta, Dusan
- Sperl, Jan
- SpringerLink (Online service)
Other Objects (12)
Incidence of hepatitis C among people who inject drugs in Ireland
Urgent action to fight hepatitis C in people who inject drugs in Europe
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study
APPEAL: a toolkit for attracting people who inject drugs with hepatitis C to healthcare systems
HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar
Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore
Knowledge of, and attitude towards, the treatment of hepatitis C in people who inject drugs
Values and preferences for hepatitis C self-testing among people who inject drugs in Kyrgyzstan
Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia
Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973–2030
HIV among people who inject drugs in Hungary
Incidence of hepatitis C among people who inject drugs in Ireland
Urgent action to fight hepatitis C in people who inject drugs in Europe
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study
APPEAL: a toolkit for attracting people who inject drugs with hepatitis C to healthcare systems
HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar
Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore
Knowledge of, and attitude towards, the treatment of hepatitis C in people who inject drugs
Values and preferences for hepatitis C self-testing among people who inject drugs in Kyrgyzstan
Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia
Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973–2030
HIV among people who inject drugs in Hungary
Incidence of hepatitis C among people who inject drugs in Ireland
Urgent action to fight hepatitis C in people who inject drugs in Europe
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study
APPEAL: a toolkit for attracting people who inject drugs with hepatitis C to healthcare systems
HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar
Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore
Knowledge of, and attitude towards, the treatment of hepatitis C in people who inject drugs
Values and preferences for hepatitis C self-testing among people who inject drugs in Kyrgyzstan
Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia
Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973–2030